Metabolic reprogramming of the urea cycle pathway in experimental pulmonary arterial hypertension rats induced by monocrotaline
Abstract Background Pulmonary arterial hypertension (PAH) is a rare systemic disorder associated with considerable metabolic dysfunction. Although enormous metabolomic studies on PAH have been emerging, research remains lacking on metabolic reprogramming in experimental PAH models. We aim to evaluat...
Main Authors: | Hai-Kuo Zheng, Jun-Han Zhao, Yi Yan, Tian-Yu Lian, Jue Ye, Xiao-Jian Wang, Zhe Wang, Zhi-Cheng Jing, Yang-Yang He, Ping Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-018-0800-5 |
Similar Items
-
Exercise improves systemic metabolism in a monocrotaline model of pulmonary hypertension
by: Ganesha Poojary, et al.
Published: (2025-01-01) -
The protective role of EP300 in monocrotaline-induced pulmonary hypertension
by: Lei Yang, et al.
Published: (2023-02-01) -
Metabolic reprogramming, oxidative stress, and pulmonary hypertension
by: Marissa D. Pokharel, et al.
Published: (2023-08-01) -
Identification of metabolic biomarkers in idiopathic pulmonary arterial hypertension using targeted metabolomics and bioinformatics analysis
by: Chuang Yang, et al.
Published: (2024-10-01) -
Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
by: Lin Huang, et al.
Published: (2022-06-01)